Earnings Feed
Start Free
Home/Filings/4/0001127602-22-011608
4//SEC Filing

Roberts Jonathan C 4

Accession 0001127602-22-011608

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 5:43 PM ET

Size

18.1 KB

Accession

0001127602-22-011608

Insider Transaction Report

Form 4
Period: 2022-04-01
CVS HEALTH CorpCVS
Roberts Jonathan C
SVP and CIO
Transactions
  • Award

    Stock Option

    2022-04-01$101.09/sh+25,987$2,627,026→ 25,987 total
    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (25,987 underlying)
Holdings

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (200,358 underlying)
    200,358

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (248,131 underlying)
    248,131

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (1,416.313 underlying)
    1,416.313

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (172,772 underlying)
    172,772

  • Common Stock

    (indirect: By GRAT)
    38,192

  • ESOP Common Stock

    (indirect: By ESOP)
    6,155.506

  • Common Stock (restricted)

    12,812

  • Common Stock

    426,024.717

  • Stock Unit

    341,392.377

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (161,318 underlying)
    161,318

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (303,010 underlying)
    303,010

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (239,355 underlying)
    239,355
Footnotes (9)
  • [F1]Option becomes exercisable in four equal installments, commencing 4/1/2023.
  • [F2]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F7]The number of shares subject to the option were calculated using a 30-day average price.
  • [F8]Options became exercisable in four equal installments, commencing 4/1/2021.
  • [F9]Option becomes exercisable in four equal installments, commencing 4/1/2022.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001410515

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:43 PM ET
Size
18.1 KB
View on SEC.gov